[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-10-P] Combination of T cell therapy and a compound 433 overcomes tumor heterogeneity

^○Pengyu Miao¹, Situo Deng¹, Daisuke Ehara^1,2, Daisuke Muraoka³, Naohisa Ogo⁴, Mitsuhiro Yoneda¹, Kiyoshi Yasui¹, Akira Asai⁴, Hiroaki Ikeda¹ (1.Dept. of Oncology, Nagasaki Univ. Grad. Sch. of Biomed. Sci, 2.Dept. of Dermatology, Nagasaki Univ. Grad. Sch. of Biomed. Sci, 3.Div. of Translational Oncoimmunology, Aichi Cancer Ctr. Res. Inst, 4.Ctr. for Drug Discovery, Grad. Div Pharm., Univ. of Shizuoka)

キーワード：

Cancer、Cytokines/ Cytokine receptors、Immunogenic cell death、Tumor antigens、Tumor heterogeneity、Adoptive T cell therapy

閲覧にはパスワードが必要です

ログイン

または